Literature DB >> 7980411

The hydrophilic domain of phospholamban inhibits the Ca2+ transport step of the Ca(2+)-ATPase.

G Hughes1, J M East, A G Lee.   

Abstract

The peptide MEKVQYLTRSAIRRASTIEMPQQAR-Cys corresponding to residues 1-25 of phospholamban was found to inhibit the ATPase activity of skeletal muscle Ca(2+)-ATPase, but to have no effect on the Ca(2+)-dependence of its activity. The peptide was found to decrease the rate of the Ca2+ transport step (E1PCa2-->E2P) by a factor of 2.4. The rate of this same step was decreased by poly(L-Arg) by a factor of 2.2. The peptide shifted the E2-E1 equilibrium of the ATPase towards E1 by a factor of 4 due to stronger binding to the E1 than to the E2 conformation of the ATPase; dissociation constants for binding to E1 and E2 were estimated as 3 and 10 microM respectively. The peptide had no effect on the level of phosphorylation by Pi in the absence of Ca2+ or on the rate of phosphorylation by ATP in the presence of Ca2+.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980411      PMCID: PMC1137357          DOI: 10.1042/bj3030511

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Functional reconstitution of the cardiac sarcoplasmic reticulum Ca2(+)-ATPase with phospholamban in phospholipid vesicles.

Authors:  H W Kim; N A Steenaart; D G Ferguson; E G Kranias
Journal:  J Biol Chem       Date:  1990-01-25       Impact factor: 5.157

2.  Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum.

Authors:  P James; M Inui; M Tada; M Chiesi; E Carafoli
Journal:  Nature       Date:  1989-11-02       Impact factor: 49.962

3.  Solid phase synthesis.

Authors:  B Merrifield
Journal:  Science       Date:  1986-04-18       Impact factor: 47.728

4.  Regulation of Ca2+-pump from cardiac sarcoplasmic reticulum.

Authors:  M Tada; M Kadoma; M Inui; J Fujii
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

5.  Expression of endoplasmic-reticulum Ca2(+)-pump isoforms and of phospholamban in pig smooth-muscle tissues.

Authors:  J A Eggermont; F Wuytack; J Verbist; R Casteels
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

6.  Participation of H+ in the Ca2(+)-induced conformational transition of 4-nitro-2,1,3-benzoxadiazole-labeled sarcoplasmic reticulum ATPase.

Authors:  S Wakabayashi; T Ogurusu; M Shigekawa
Journal:  Biochemistry       Date:  1990-11-27       Impact factor: 3.162

7.  Mechanism of inhibition of the (Ca2(+)-Mg2+)-ATPase by nonylphenol.

Authors:  F Michelangeli; S Orlowski; P Champeil; J M East; A G Lee
Journal:  Biochemistry       Date:  1990-03-27       Impact factor: 3.162

8.  Localization of the hinge region of the Ca(2+)-ATPase of sarcoplasmic reticulum using resonance energy transfer.

Authors:  K J Baker; J M East; A G Lee
Journal:  Biochim Biophys Acta       Date:  1994-06-01

9.  Covalent and non-covalent inhibitors of the phosphate transporter of sarcoplasmic reticulum.

Authors:  H I Stefanova; J M East; A G Lee
Journal:  Biochim Biophys Acta       Date:  1991-05-07

10.  Calcium-activated tension of skinned muscle fibers of the frog. Dependence on magnesium adenosine triphosphate concentration.

Authors:  R E Godt
Journal:  J Gen Physiol       Date:  1974-06       Impact factor: 4.086

View more
  11 in total

1.  Kinetics studies of the cardiac Ca-ATPase expressed in Sf21 cells: new insights on Ca-ATPase regulation by phospholamban.

Authors:  J E Mahaney; J M Autry; L R Jones
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

2.  Luminal dissociation of Ca2+ from the phosphorylated Ca2+-ATPase is sequential and gated by Mg2+.

Authors:  R C Duggleby; M East; A G Lee
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

Review 3.  What the structure of a calcium pump tells us about its mechanism.

Authors:  A G Lee; J M East
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

4.  Cytoplasmic interactions between phospholamban residues 1-20 and the calcium-activated ATPase of the sarcoplasmic reticulum.

Authors:  P Sharma; V B Patchell; Y Gao; J S Evans; B A Levine
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

5.  Epigallocatechin-3-gallate has dual, independent effects on the cardiac sarcoplasmic reticulum/endoplasmic reticulum Ca2+ ATPase.

Authors:  M E Kargacin; T L Emmett; Gary J Kargacin
Journal:  J Muscle Res Cell Motil       Date:  2011-08-05       Impact factor: 2.698

6.  An investigation of the mechanism of inhibition of the Ca(2+)-ATPase by phospholamban.

Authors:  G Hughes; A P Starling; R P Sharma; J M East; A G Lee
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

7.  Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer.

Authors:  P Pollesello; A Annila; M Ovaska
Journal:  Biophys J       Date:  1999-04       Impact factor: 4.033

8.  Mechanism of inhibition of Ca(2+)-ATPase by myotoxin a.

Authors:  K J Baker; J M East; A G Lee
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

9.  Evidence that the effects of phospholipids on the activity of the Ca(2+)-ATPase do not involve aggregation.

Authors:  A P Starling; J M East; A G Lee
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

10.  Amide-type local anesthetics action on the sarcoplasmic reticulum Ca-ATPase from fast-twitch skeletal muscle.

Authors:  D E Di Croce; P W Trinks; C de La Cal; G A Sánchez; D Takara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-06-20       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.